Back

Single-Cell Cross-Species Profiling identifies Conserved Transcriptional Networks in Early Pancreatic Tumourigenesis.

Goossens, C.; Lolos, C.; Lopez-Perez, A.; Kessels, M.; Deom, E.; Bletard, N.; Bernard, P.; Flasse, L.; Voz, M. L.

2026-03-05 cancer biology
10.64898/2026.03.03.708839 bioRxiv
Show abstract

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and carries the poorest prognosis among all cancers, largely because it is frequently diagnosed at metastatic stages. It is therefore critical to identify reliable markers of preinvasive stages and to decipher the network driving preinvasive lesions to invasive carcinoma. Here, we generated a zebrafish model in which KRASG12D is specifically expressed in pancreatic acinar cells, inducing acinar-to-ductal metaplasia that faithfully mirrors mammalian tumorigenesis. Single cell RNA-seq allowed us to capture transcriptional changes occurring at early stages of the disease. Cross-species comparison with mouse and human scRNAseq transcriptomes revealed a striking conservation of the genes upregulated during metaplasia, triggering common signalling pathways and regulatory programs. Notably, metaplastic cells reactivate a broad set of developmental genes expressed in multipotent pancreatic progenitors. Mapping the acinar-to-cancer trajectories revealed a set of cytoskeletal and migration-related genes specifically upregulated during the late phase of metaplasia, immediately prior to malignant transformation, likely conferring invasive potential to these cells. SCENIC analysis further identified regulatory networks that become progressively activated as cells transition toward cancer, suggesting their involvement in the acquisition of malignant traits. In conclusion, our cross-species comparison demonstrates a high degree of conservation in the molecular mechanisms driving pancreatic cancer progression from early to late stages across evolutionarily distant species, including zebrafish, mouse, and human, highlighting critical pathways that should be targeted to prevent cancer progression. To allow researchers to easily explore gene expression profiles during pancreatic cancer progression across all three species, the datasets are publicly accessible via a user-friendly web platform (https://www.zddm.page.gd/)

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Gastroenterology
40 papers in training set
Top 0.3%
7.3%
2
Gut
36 papers in training set
Top 0.1%
7.3%
3
Nature Communications
4913 papers in training set
Top 28%
6.5%
4
eLife
5422 papers in training set
Top 16%
4.9%
5
Developmental Cell
168 papers in training set
Top 4%
4.9%
6
EMBO Molecular Medicine
85 papers in training set
Top 0.2%
4.9%
7
Genome Medicine
154 papers in training set
Top 2%
4.4%
8
Disease Models & Mechanisms
119 papers in training set
Top 0.4%
3.6%
9
Cell Reports
1338 papers in training set
Top 17%
3.1%
10
Scientific Reports
3102 papers in training set
Top 41%
3.1%
11
The Journal of Pathology
22 papers in training set
Top 0.1%
2.1%
50% of probability mass above
12
Cancer Cell
38 papers in training set
Top 0.7%
2.1%
13
Cell Death & Disease
126 papers in training set
Top 0.7%
1.9%
14
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.3%
1.8%
15
Oncogene
76 papers in training set
Top 0.9%
1.8%
16
Cancer Discovery
61 papers in training set
Top 1%
1.7%
17
PLOS ONE
4510 papers in training set
Top 53%
1.7%
18
Nature Genetics
240 papers in training set
Top 5%
1.3%
19
JCI Insight
241 papers in training set
Top 4%
1.3%
20
Communications Biology
886 papers in training set
Top 14%
1.2%
21
PLOS Computational Biology
1633 papers in training set
Top 19%
1.2%
22
Molecular Cancer Research
42 papers in training set
Top 0.5%
1.0%
23
Molecular Cancer
14 papers in training set
Top 0.7%
0.9%
24
Advanced Science
249 papers in training set
Top 16%
0.9%
25
iScience
1063 papers in training set
Top 29%
0.8%
26
BMC Cancer
52 papers in training set
Top 2%
0.8%
27
Cancer Research
116 papers in training set
Top 3%
0.8%
28
Neoplasia
22 papers in training set
Top 0.6%
0.8%
29
Cell Death & Differentiation
48 papers in training set
Top 0.7%
0.8%
30
Cells
232 papers in training set
Top 6%
0.8%